NAACCR Item #3820: CEA Pretreatment Lab Value
| Item # | Length | Source of Standard | Year Implemented | Version Implemented | Year Retired | Version Retired |
|---|---|---|---|---|---|---|
| 3820 | 6 | NAACCR | 2018 | 18 |
NAACCR XML:
Tumor.ceaPretreatmentLabValue
Description
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value records the CEA value prior to treatment. CEA is a nonspecific tumor marker that has prognostic significance for colon and rectum cancer.
Rationale
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 3.
Codes
| 0.0 | 0.0 nanograms/milliliter (ng/m) exactly |
| 0.1-9999.9 | 0.1-9999.9 ng/ml (Exact value to nearest tenth in ng/ml) |
| XXXX.1 | 10,000 ng/ml or greater |
| XXXX.7 | Test ordered, results not in chart |
| XXXX.8 | Not applicable: Information not collected for this case (If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.) |
| XXXX.9 | Not documented in medical record CEA (Carcinoembryonic Antigen) Pretreatment Lab Value not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.